Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- CIF-test label "CIF Test" assertion.
- iupac-assets label "IUPAC WorldFAIR Activity" assertion.
- VODAN_A label "Virus Outbreak Data Network (VODAN) Africa" assertion.
- EPND label "European Platform for Neurodegenerative Diseases" assertion.
- ADWB label "Alzheimer’s Disease Workbench" assertion.
- ADWB label "Alzheimer Disease Workbench" assertion.
- RDF label "RDF | Resource Description Framework" assertion.
- EPND-CS1-SHACL-Template label "EPND CS1 SHACL Template | Shape constraint language template for EPND Case study 1" assertion.
- EPND-CS1-Cedar-WB-Template label "EPND CS1 Cedar Workbench Template | Metadata template for Case Study 1 of the EPND platform" assertion.
- SNOMED-CT label "SNOMED CT ontology | SNOMED Clinical Terms Ontology" assertion.
- association label "Tramadol was reported to be an effective or very effective antidepressant by 94.6% of patients (123/130) who provided ratings submitted to User Reviews for Tramadol to Treat Depression. Tramadol addiction has been reported in individuals who have consumed high doses for prolonged periods." assertion.
- context label "Adults" assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- DB00186 label "Lorazepam" assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- MONDO_0005433 label "alcohol withdrawal delirium" assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- MONDO_0005567 label "substance withdrawal syndrome" assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- context label "Adults" assertion.
- association label "Off-label (non-FDA-approved) uses for Lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting (adjunct or breakthrough), as well as psychogenic catatonia." assertion.
- context label "Adults" assertion.
- association label "Paliperidone palmitate was off-label used to control her aggression, irritability, and psychosis. After induction doses (150 mg and 100 mg intramuscularly, given 1 wk apart), she developed intermittent swelling of the face, eyelids, and lips on day 17 after the initial dose, and the edema was explicitly seen on day 20. The diagnosis was paliperidone palmitate-induced angioedema." assertion.
- context label "adults" assertion.
- association label "Off-label, the drug is useful for premature ejaculation and restless leg syndrome refractory to other medications. For the off-label use of tramadol for premature ejaculation, both sporadic and daily use is effective for the treatment of the condition. Patients indicate a preference for "as needed" therapy for premature ejaculation due to the lack of side effects compared to the daily use of tramadol." assertion.
- context label "adults" assertion.
- association label "Off-label, non-FDA approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity. In the pediatric population, bupropion is used off-label for ADHD." assertion.
- context label "adults" assertion.
- association label "Off-label, non-FDA approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity. In the pediatric population, bupropion is used off-label for ADHD." assertion.
- context label "adults" assertion.
- association label "Off-label, non-FDA approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity. In the pediatric population, bupropion is used off-label for ADHD." assertion.
- context label "adults" assertion.
- association label "Off-label, non-FDA approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity. In the pediatric population, bupropion is used off-label for ADHD." assertion.
- MONDO_0011122 label "obesity disorder" assertion.
- context label "children" assertion.
- association label "Off-label, non-FDA approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity. In the pediatric population, bupropion is used off-label for ADHD." assertion.
- context label "Children and adolescents" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- context label "Children and adolescents" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- context label "Adults" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- context label "Adults" assertion.
- association label "Paroxetine is not FDA approved for use in children and adolescents less than 18 years of age; however, clinicians do use off-label in this group." assertion.
- context label "Adults" assertion.
- association label "There are other off-label uses of imipramine as in the treatment of chronic neuropathic pain and panic disorder." assertion.
- context label "Adults" assertion.
- association label "This profile suggests that asenapine may be of particular value off label for bipolar depression, anxiety, and aggression." assertion.
- DB06216 label "Asenapine" assertion.
- DB06216 label "Asenapine" assertion.
- DB06216 label "Asenapine" assertion.
- DB06216 label "Asenapine" assertion.
- context label "Adults" assertion.
- association label "This profile suggests that asenapine may be of particular value off label for bipolar depression, anxiety, and aggression." assertion.
- context label "Adults" assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- context label "Adults" assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- context label "Adults" assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- MONDO_0006624 label "overactive bladder (disease)" assertion.
- context label "Adults" assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- context label "Adults" assertion.
- association label "Trazodone, a serotonin modulator, is used off-label for insomnia." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "Trazodone is also used off-label for anxiety, Alzheimer disease, substance abuse, bulimia, and fibromyalgia due to its serotonergic receptor antagonism and serotonin reuptake inhibiting effects." assertion.
- context label "Adults" assertion.
- association label "It also has off label use as monotherapy or adjunctive therapy for the treatment of mania, restless leg syndrome, insomnia, tardive dyskinesia, and REM sleep behavior disorder." assertion.